Current NDC auxiliary source row compounder:4663
This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.
Complete normalized row#
- Record Source
- ndc_compounder_zip
- Product Ndc Raw
- 71300-6555
- Product Ndc
- 71300-6555
- Product Ndc Digits
- 713006555
- Product Type Name
- HUMAN COMPOUNDED DRUG
- Proprietary Name
- Dexamethasone sodium phosphate and Lidocaine HCl
- Proprietary Name Suffix
- Nonproprietary Name
- DEXAMETHASONE SODIUM PHOSPHATE AND LIDOCAINE HCL
- Dosage Form Name
- INJECTION, SOLUTION
- Route Name
- INTRA-ARTICULAR; SOFT TISSUE; SUBCUTANEOUS
- Marketing Category Name
- OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
- Labeler Name
- Nubratori Inc.
- Establishment Name
- Nubratori Inc.
- Establishment Fei
- Substance Name
- DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE
- Active Ingredients Info
- 3.33 mg/1 mL; 6.67 mg/1 mL
- History Active Ingredients Raw
- DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE
- History Active Ingredients Info Raw
- 3.33 mg/1 mL; 6.67 mg/1 mL
- History Dosage Raw
- INJECTION, SOLUTION
- Dea Schedule
- Package Ndc Raw
- 71300-6555-1
- Package Ndc
- 71300-6555-1
- Package Ndc Digits
- 7130065551
- Package Ndc11
- 71300655501
- Package Description
- 1.5 mL in 1 BOX (71300-6555-1)
- Reporting Period Raw
- 2025-1
- Reporting Period
- 2025-1
- Normalization Status
- valid
- Source Archive
- compounders_ndc_directory.zip
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Last Modified
- Fri, 18 Sep 2026 15:17:23 GMT
- Source Archive Sha256
- 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
- Source Member Sha256
- f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
- Source Record Id
- compounder:4663
- Source Row Number
- 4663
- Source Row Hash
- fde3ba31f9db6a0dd09ce20b494b22e30cd7a5f1aac796ede311d3a79f6e73b6
- Import Run Id
- 20261119T172627Z
- Loaded At
- 2026-11-19 17:42:45
Exact raw FDA source fields#
{
"ROUTENAME": "INTRA-ARTICULAR; SOFT TISSUE; SUBCUTANEOUS",
"PRODUCTNDC": "71300-6555",
"DEASCHEDULE": "",
"LABELERNAME": "Nubratori Inc.",
"SUBSTANCENAME": "DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE",
"DOSAGEFORMNAME": "INJECTION, SOLUTION",
"NDCPACKAGECODE": "71300-6555-1",
"PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
"PROPRIETARYNAME": "Dexamethasone sodium phosphate and Lidocaine HCl",
"REPORTINGPERIOD": "2025-1",
"NONPROPRIETARYNAME": "DEXAMETHASONE SODIUM PHOSPHATE AND LIDOCAINE HCL",
"PACKAGEDESCRIPTION": "1.5 mL in 1 BOX (71300-6555-1) ",
"ACTIVEINGREDIENTSINFO": "3.33 mg/1 mL; 6.67 mg/1 mL",
"MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
"PROPRIETARYNAMESUFFIX": ""
}Normalization notes#
[]Current status projection#
- Dataset
- compounder
- Record Source
- ndc_compounder_zip
- Source Record Id
- compounder:4663
- Source Row Number
- 4663
- Status Scope
- package
- Lookup Ndc
- 71300-6555-1
- Lookup Ndc Digits
- 7130065551
- Product Ndc
- 71300-6555
- Product Ndc Digits
- 713006555
- Package Ndc
- 71300-6555-1
- Package Ndc Digits
- 7130065551
- Package Ndc11
- 71300655501
- Product Id
- Status Code
- COMPOUNDER
- Status Label
- Outsourcing facility compounded drug report
- Reporting Period Raw
- 2025-1
- Reporting Period
- 2025-1
- Source Table
- fda_ndc_aux_compounder
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Row Hash
- fde3ba31f9db6a0dd09ce20b494b22e30cd7a5f1aac796ede311d3a79f6e73b6
- Import Run Id
- 20261119T172627Z
- Loaded At
- 2026-11-19 17:42:45